A 2-Year, Prospective, Blinded-Rater, Open-Label, Active-Controlled, Multicenter, Randomized Study of Long-Term Efficacy and Effectiveness Comparing Risperdal Consta and Abilify (Aripiprazole) in Adults With Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2011
At a glance
- Drugs Aripiprazole; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 14 Jul 2009 Actual patient number (355) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2008 Planned number of patients changed from 316 to 357 as reported by ClinicalTrials.gov.